Home
About Us
As medical marijuana becomes more widely available in the US, one Canadian company is looking to take advantage.
Mydecine Innovations Group Inc.
has entered into subscription agreements with third-party investors to raise up to $3,750,000 through the sale of up to 18,750,000 common shares at a price of $0.20 per share, per a press release.
The company expects to close the deal on or about Sept.
16, 2023, per the release.
Mydecine, which is based in Vancouver, is a biotechnology company "engineering the next wave of innovative medications and treatment protocols to directly address mental health with a particular emphasis on addiction and PTSD," per the release.
Mydecine's lead product is MYCO-006, an analogue of the active ingredient in marijuana known as MDMA, or ecstasy, that has been shown to be effective in treating pain, anxiety, depression, addiction, and post-traumatic stress disorder, among other conditions.
Mydecine's CEO, Joshua Bartch, tells the CBC that the company's research and development team is working with artificial intelligence to create medications that are affordable to the general public upon FDA and Health Canada approval.
(New York Gov.
Andrew Cuomo has signed a bill making recreational marijuana legal in the state.
Selected Grant News Headlines
A customized collection of grant news from foundations and the federal government from around the Web.
People of color make up about 20% of Spokane County, Wash., but they own about 8% of the county's businesses, reports the Spokesman-Review. That's why the Spokane Workforce Council is...more
The Oklahoma Arts Council has released its annual list of grant requests, and it's a doozy. This year's list includes a call for artists to "bring the arts to other statewide organizations," as...more
Northern Illinois University is looking for a full-time assistant coach for its men's basketball team, the Chicago Tribune reports. The ideal candidate will have at least three years' experience...more
When it comes to climate change, France's Beaujolais region is no stranger. Two decades ago, farmers there were fooled by a warm spell in March. The buds on the vines burst earlier than usual,...more
If you're an investor in Global Warming Solutions Inc. (GWSO), you're going to want to stop reading now. The clean-energy company's stock has been suspended from trading on the...more
A new study from the European Patent Office finds that Europe is leading the world in the development of new technologies in water-related fields. Specifically, companies, researchers, and...more
"Hawai'i has remarkably innovative climate leadersacross all sectorsworking to support an equitable, clean, climate-resilient future." So says Jeff Mikulina, executive director of Climate...more
A new $100 million fund aims to make a positive difference in the world's food and water supply. The Natural Ventures Fund I, a 10-year closed fund, is the first from a consortium of investors...more
"There are few people as informed about the latest state of AI developments and its level of adoption in financial services, who have also sat shoes in the shoes of investment managers and asset...more
The Savanna Institute in Urbana, Ill., is looking for a full-time financial manager to oversee its 70,000-square-foot headquarters and budgeting and accounting practices, the Chicago Tribune...more
Nonprofit Management News from...
Winter Park Health Foundation
Community Foundation of Sarasota County
Daniels Fund
Colorado Trust
Denver Foundation
Gates Foundation
Gulf Coast Community Foundation
Wells Fargo Foundation
Ewing Marion Kauffman Foundation
Lynde and Harry Bradley Foundation
Rockefeller Foundation
Social Entrepreneurship
Spotlight
Halcyon Incubator Selects Inaugural Class of Fellows
Washington, D.C. based incubator for social entrepreneurs, Halcyon Incubator, has selected seven ventures to move into the newly renovated Halcyon House in September for its inaugural class of fellows.
